Intensive phase
Showing 1 - 25 of >10,000
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
Stroke, Spinal Cord Injuries, Chronic Disease Trial in Herentals, Leuven (Intensive rehabilitation programme)
Recruiting
- Stroke
- +2 more
- Intensive rehabilitation programme
-
Herentals, Belgium
- +1 more
Jul 24, 2023
Obesity Hypoventilation Syndrome (OHS), Chronic Obstructive Lung Disease, Interstitial Lung Disease Trial in Riga (PHASE 1
Recruiting
- Obesity Hypoventilation Syndrome (OHS)
- +3 more
- PHASE 1 Lowenstein medical BiLevel Prisma 25ST device: withount oxygen support.
- PHASE 2. Continous/Bilevel positive airway presure with additional oxygen support by Devilbiss 525 KS oxygen concentrator
-
Riga, LatviaPauls Stradins Clinical Univeristy Hospital
Oct 18, 2023
Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Neoplasm
- Magrolimab
- +2 more
- (no location specified)
Apr 24, 2023
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Ivosidenib Oral Tablet
- Azacitidine
-
Vienna, Austria
- +3 more
Jun 8, 2023
Fluid Overload, Fluid Loss Trial in Seoul (Active fluid management with BIA monitoring, Conventional fluid management without
Completed
- Fluid Overload
- Fluid Loss
- Active fluid management with BIA monitoring
- Conventional fluid management without BIA monitoring
-
Seoul, Seocho-gu, Banpo-dong Banpodaero 222, Korea, Republic ofDivision of Trauma and Surgical Critical Care, Department of Sur
Oct 16, 2023
Melioidosis Trial in Udon Thani (Ceftazidime or meropenem, ARV-1801, Placebo)
Recruiting
- Melioidosis
- Ceftazidime or meropenem
- +2 more
-
Nai Muang, Thailand
- +4 more
Nov 29, 2022
Post-intensive Care Syndrome, Transitional Care, Critical Care Trial in Pittsburgh (PICTURE-THIS, Enhanced Usual Care, Run-In
Recruiting
- Post-intensive Care Syndrome
- +3 more
- PICTURE-THIS
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 10, 2023
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
Active Second Stage Trial in Paris ("Moderate" management, "Intensive" management)
Completed
- Active Second Stage
- "Moderate" management
- "Intensive" management
-
Paris, FranceCochin Hospital
Dec 9, 2021
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Acute Myeloid Leukemia Trial (with or without venetoclax)
Not yet recruiting
- Acute Myeloid Leukemia
- with or without venetoclax
- (no location specified)
Apr 29, 2022
Aphasia, Apraxia of Speech, Dysarthria Trial in Stockholm (Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech)
Recruiting
- Aphasia
- +2 more
- Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
-
Stockholm, SwedenCLINTEC, Logopedi, F67 Karolinska Universitetssjukhuset Huddinge
Apr 6, 2022
Septic Shock Trial in Angers (increase of mean arterial pressure at 80-85 mmHg., increase of mean arterial pressure at 65-70
Recruiting
- Septic Shock
- increase of mean arterial pressure at 80-85 mmHg.
- increase of mean arterial pressure at 65-70 mmHg.
-
Angers, FranceCHU Angers. Médecine Intensive Réanimation et médecine hyperbare
Oct 30, 2022
Sedation in the ICU Trial in Guiyang (Remimazolam Tosilate)
Recruiting
- Sedation in the ICU
- Remimazolam Tosilate
-
Guiyang, Guizhou, ChinaThe Affiliated Hospital of Guizhou Medical University
Jun 27, 2023
Sedation Trial in Nashville (Isoflurane, Propofol)
Recruiting
- Sedation
-
Nashville, TennesseeVanderbilt University Medical Center
May 2, 2022
Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)
Terminated
- Acute Myeloid Leukemia
- Gemtuzumab Ozogamicin 147
- +3 more
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital Heidelberg, Internal Medicine V
Jun 27, 2022
Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)
Recruiting
- Acute Myeloid Leukemia
-
Firenze, ItalyAz. Ospedaliero - Universitaria Careggi
Jan 3, 2022
HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)
Completed
- HIV
- Burkitt's Lymphoma
- Induction Phase
- +4 more
-
Aviano (PN), Italy
- +7 more
Aug 2, 2022
Autism Spectrum Disorder Trial in St. John's (Alternate Coaching and Video Feedback Phase 1, Weekly Coaching in Phase 1, Weekly
Active, not recruiting
- Autism Spectrum Disorder
- Alternate Coaching and Video Feedback Phase 1
- +4 more
-
St. John's, Newfoundland and Labrador, CanadaDepartment of Health and Community Services, Government of Newfo
Mar 14, 2022